Christopher Mutz, Head of Rare Disease: Ani Pharmaceuticals ANIP Sell · Filed 03/10

Trade details

Type: Insider sale
Amount: $157,420.62
Shares · price: 2,121 sh · $74.22 a share
Held after: 101,387 sh
Stock: Ani Pharmaceuticals ANIP
Person: Christopher MutzHead of Rare Disease
Trade date: 26/03/06
Filed: 26/03/10
Days to filing: 4 days

Sold 2.0% of holdings

Share of holding sold: 2.0%

Ani Pharmaceuticals trades, last 26 weeks

What else happened in Ani Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/04~04/05

Christopher Mutz's recent trades

Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$226.5K
3,162 sh
$226.5K
Filed 03/13
Traded 03/13
Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$267.2K
3,602 sh
$267.2K
Filed 03/10
Traded 03/09
Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$30.9K
417 sh
$30.9K
Filed 03/04
Traded 03/02
Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$415.3K
5,323 sh
$415.3K
Filed 02/23
Traded 02/20
Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$538.3K
7,032 sh
$538.3K
Filed 02/17
Traded 02/12

Christopher Mutz, Executive — sold $157.4K of Ani Pharmaceuticals ANIP · 2.0% of holdings · 10b5-1 plan | Whalegun